| Patient | Richard Roundtree |
|---|---|
| Date of birth | 1975-07-09 |
| Identifiers | MRN HR-ML015-SYN; SSN (made up) 000-15-8410 |
| Document date | 2026-10-05 |
| Author | Farah Siddiqui, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Man of 51 with a new 1.5 cm firm, painless lump eccentric to the left nipple and a palpable left axillary node; breast cancer suspected. Diagnostic mammography, ultrasound, and core biopsy are booked for tomorrow. Please see him as soon as the results are back to plan surgery. [S]
Urgency: Urgent suspected-cancer pathway, within one week. [S]
Questions for the consultant:
Mr. Roundtree is seen at the request of Dr. Carrington. A few days before his first visit he found a painless lump under the left nipple in the shower and thought at first that it was the breast enlargement he had as a boy. Diagnostic mammography and ultrasound of both breasts and both axillae five days ago showed a 1.6 cm irregular retroareolar mass on the left and one abnormal left axillary node, with a normal right breast and axilla. Core biopsies of both show invasive ductal carcinoma, grade 3, ER 95 percent, PR 85 percent, HER2 1+, Ki-67 30 percent, with metastatic carcinoma in the node. He has no bone pain, cough, headache, or weight loss. He is fit, trains most days, and works as an actor. He says he did not know a man could get breast cancer, and he is worried about privacy at work. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast cancer | active | confirmed | C50.122 | S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D). |
| Estrogen receptor-positive status of the breast cancer | active | confirmed | Z17.0 | S — Synthetic receptor result; his tumor biology was not made public. |
| New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy booked | resolved | confirmed | N63.42 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D). |
Vital signs recorded on 2026-10-05; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; anxious but composed |
| Breasts | Left: 1.5 cm firm, irregular mass eccentric to the nipple at 2 o'clock, not fixed to the chest wall or skin; no nipple retraction or discharge. Right: no mass and no glandular enlargement |
| Lymph nodes | One firm, mobile 1 cm left axillary node; no right axillary, supraclavicular, or cervical nodes |
| Musculoskeletal | Full shoulder movement on both sides |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-05 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-10-05 | Leukocytes [#/volume] in Blood by Automated count | 6.6 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-10-05 | Neutrophils [#/volume] in Blood by Automated count | 3.9 | 10*3/uL | 1.5-7.7 10*3/uL | Normal | S |
| 2026-10-05 | Platelets [#/volume] in Blood by Automated count | 246 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-10-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-10-05 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-10-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-10-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 89 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-10-05 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-10-05 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-10-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 2026-10-05 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 8-48 U/L | Normal | S |
| 2026-10-05 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 71 | U/L | 40-129 U/L | Normal | S |
| 2026-10-05 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-10-05 | Albumin [Mass/volume] in Serum or Plasma | 4.4 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-10-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Data reviewed: Diagnostic mammography and ultrasound of both breasts and both axillae; core biopsy pathology of the breast mass and the axillary node with ER, PR, HER2, and Ki-67; today's preoperative blood count and chemistry, all normal. [S]